Pharmacists in Warfield, KY Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Michael Tyler Hall Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9145 Beauty Rd, Warfield, KY 41267 Phone: 606-395-0522 |
 Dr. Elizabeth Ashley Endicott, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9145 Beauty Rd, Warfield, KY 41267 Phone: 606-395-0522 Fax: 606-395-5480 |
Chelsey Kurkowski, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9145 Beauty Rd, Warfield, KY 41267 Phone: 606-395-0522 |
News Archive
E2F1 transcription factor inhibition reduces EGFR expression and invasive potential of melanoma cells
Inhibition of transcription factor E2F1 reduced epidermal growth factor receptor (EGFR) expression and reduced the invasive potential but not proliferation of metastatic melanoma cells, according to a brief communication published online December 23 in the Journal of the National Cancer Institute.
New research offers ways in which investigators can reduce amount of Cd in foods
A number of environmental toxins pose considerable health threats to humans, and the heavy metal cadmium (Cd) ranks high on the list. Most of us are exposed to it through plant-derived foods such as grains and vegetables. Now, new research offers ways in which investigators can reduce the amount of Cd found in the food we eat, according to a review published online September 12th in the Cell Press journal Trends in Plant Science.
Study could lead to better understanding of how Notch protein directs healthy development of organs
Johns Hopkins researchers report they have figured out how the aptly named protein Botch blocks the signaling protein called Notch, which helps regulate development. In a report on the discovery, to appear online April 24 in the journal Cell Reports, the scientists say they expect the work to lead to a better understanding of how a single protein, Notch, directs actions needed for the healthy development of organs as diverse as brains and kidneys.
Morphotek receives NIAID grant to develop human mAb therapies against staphylococcal-derived pathogens
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced today that it was awarded $843,289 in funding from the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to support the development of human monoclonal antibody (mAb) therapies against staphylococcal-derived toxin(s).
UK's reduced health inequality targets more likely to benefit the rich
UK targets to reduce health inequalities could end up improving the health of the richest fastest, warn researchers in this week's BMJ.
› Verified 7 days ago